Fact CheckerSign in

NCT06772857Completed

Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

The purpose of study is to compare the effect of different exercise modes on insulin resistance and body composition in obese patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
29 Dec 2024
Start date
18 Jul 2024
Primary completion date
30 Mar 2025
Lead sponsor
Cairo University
Diseases
Obesity
NCT number
NCT06772857

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 18 Jul 2024 to the primary completion date, 30 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of weight loss medications.

Other illness

  • Uncontrolled diabetes.
  • Uncontrolled hypertension.
  • Cardiovascular disease.
  • Respiratory disease.
  • Hepatic disease.
  • Severe life-limiting illness (e.g., cancer).
  • Orthopedic or neurological disorders that limit exercise participation.
  • Endocrine disorders.
  • Kidney disease.

Who the study is looking for

  • Sixty obese prediabetic patients from both sexes with ages ranging from 30 to 40 years old.
  • Body mass index (BMI) ranging from 30 to 34.9 kg/m².
  • Insulin resistance as assessed by the homeostasis model assessment for insulin resistance (HOMA-IR) levels above 1.9.
  • Blood glucose levels ranging from 100 to 125 mg/dL (5.6-6.9 mmol/L).
  • Patients will receive the same medical and diet regimen, with instructions not to change their physical activity during the study.
  • HbA1c levels between 6.0% and 6.5%, indicating high risk for diabetes and possible consideration for prevention interventions.

Age in the registry: 30 years to 40 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cairo University
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.